Regis Common Stock vs Net Receivables Analysis
REG Stock | 6.68 0.13 1.98% |
Regis Healthcare financial indicator trend analysis is much more than just breaking down Regis Healthcare prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Regis Healthcare is a good investment. Please check the relationship between Regis Healthcare Common Stock and its Net Receivables accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regis Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Common Stock vs Net Receivables
Common Stock vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Regis Healthcare Common Stock account and Net Receivables. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Regis Healthcare's Common Stock and Net Receivables is 0.41. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Regis Healthcare, assuming nothing else is changed. The correlation between historical values of Regis Healthcare's Common Stock and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Regis Healthcare are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Common Stock i.e., Regis Healthcare's Common Stock and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.41 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Common Stock
Net Receivables
Most indicators from Regis Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Regis Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regis Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Selling General Administrative is likely to drop to about 35.4 M in 2024. Tax Provision is likely to gain to about (10.2 M) in 2024
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 41.3M | 72.6M | 80.5M | 58.2M | EBITDA | 55.9M | 96.8M | 191.4M | 107.7M |
Regis Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Regis Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Regis Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 1.8B | 1.8B | 1.7B | 1.8B | 1.6B | |
Other Current Liab | 1.3B | 1.4B | 1.5B | 1.5B | 1.8B | 1.2B | |
Total Current Liabilities | 1.4B | 1.4B | 1.5B | 1.5B | 1.8B | 1.2B | |
Total Stockholder Equity | 127.8M | 142.0M | 79.0M | 38.4M | (22.9M) | (21.7M) | |
Other Liab | 69.0M | 60.8M | 42.1M | 21.4M | 24.7M | 38.5M | |
Accounts Payable | 10.3M | 9.0M | 13.3M | 12.4M | 11.3M | 12.0M | |
Cash | 3.8M | 3.9M | 4.2M | 61.3M | 64.9M | 68.2M | |
Other Assets | 148.1M | 158.6M | 1.0 | 116.6M | 134.1M | 91.1M | |
Long Term Debt | 232.6M | 131.4M | 95.7M | 67.3M | 60.6M | 57.6M | |
Net Receivables | 19.1M | 7.5M | 10.7M | 15.3M | 15.8M | 16.6M | |
Inventory | 1.1M | 4.4M | 5.2M | 1.8M | 7.4M | 7.8M | |
Other Current Assets | 4.0M | 6.1M | 20.7M | 33.4M | 22.1M | 14.8M | |
Total Liab | 1.7B | 1.6B | 1.7B | 1.7B | 1.8B | 1.4B | |
Common Stock | 273.5M | 273.5M | 273.6M | 273.8M | 274.1M | 258.1M | |
Property Plant Equipment | 1.2B | 1.1B | 1.1B | 1.1B | 1.3B | 956.3M | |
Short Long Term Debt Total | 248.5M | 153.4M | 113.3M | 71.1M | 3.8M | 3.7M | |
Property Plant And Equipment Net | 1.2B | 1.1B | 1.1B | 1.1B | 1.2B | 1.1B | |
Net Debt | 244.7M | 149.5M | 109.2M | 9.8M | (61.1M) | (58.0M) | |
Retained Earnings | (48.2M) | (34.3M) | (97.6M) | (139.1M) | (201.9M) | (191.8M) | |
Non Current Assets Total | 1.8B | 1.7B | 1.7B | 1.6B | 1.7B | 1.5B | |
Non Currrent Assets Other | (1.6B) | (1.6B) | (239.9M) | (239.9M) | 4.0M | 4.2M | |
Cash And Short Term Investments | 3.8M | 3.9M | 4.2M | 61.3M | 64.9M | 68.2M | |
Common Stock Shares Outstanding | 300.8M | 300.9M | 300.8M | 300.9M | 301.0M | 242.1M | |
Liabilities And Stockholders Equity | 1.8B | 1.8B | 1.8B | 1.7B | 1.8B | 1.7B | |
Non Current Liabilities Total | 300.2M | 198.2M | 186.6M | 135.5M | 8.4M | 8.0M | |
Other Stockholder Equity | (225.3M) | (239.2M) | (176.0M) | (134.7M) | (121.2M) | (127.3M) | |
Total Current Assets | 28.0M | 21.9M | 40.7M | 111.9M | 102.8M | 58.8M | |
Accumulated Other Comprehensive Income | (97.5M) | (97.3M) | (97.0M) | (96.3M) | (95.1M) | (99.8M) | |
Short Term Debt | 8.9M | 16.0M | 12.4M | (3.3M) | 919K | 873.1K | |
Net Tangible Assets | (316.4M) | (321.8M) | (323.7M) | (282.9M) | (254.6M) | (267.4M) | |
Current Deferred Revenue | 8.6M | 8.2M | 6.0M | 4.1M | 2.6M | 2.4M | |
Property Plant And Equipment Gross | 1.2B | 1.4B | 1.5B | 1.5B | 1.8B | 1.2B | |
Short Long Term Debt | 1.9M | 7.9M | 14.9M | 11.4M | 10.3M | 9.7M | |
Long Term Investments | 148.1M | 158.6M | 163.1M | 116.6M | 134.1M | 145.3M | |
Long Term Debt Total | 239.6M | 137.4M | 100.9M | 70.3M | 63.3M | 60.1M | |
Net Invested Capital | 387.8M | 288.3M | 186.1M | 105.7M | 95.2M | 90.4M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Regis Stock Analysis
When running Regis Healthcare's price analysis, check to measure Regis Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regis Healthcare is operating at the current time. Most of Regis Healthcare's value examination focuses on studying past and present price action to predict the probability of Regis Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regis Healthcare's price. Additionally, you may evaluate how the addition of Regis Healthcare to your portfolios can decrease your overall portfolio volatility.